FMC - Sanford is a medicare approved dialysis facility center in Sanford, Florida and it has 21 dialysis stations. It is located in Seminole county at 419 E First St, Sanford, FL, 32771. You can reach out to the office of FMC - Sanford at (407) 688-6765. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Sanford has the following ownership type - Profit. It was first certified by medicare in December, 1980. The medicare id for this facility is 102546 and it accepts patients under medicare ESRD program.
| Name | FMC - Sanford |
|---|---|
| Location | 419 E First St, Sanford, Florida |
| No. of Dialysis Stations | 21 |
| Medicare ID | 102546 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 419 E First St, Sanford, Florida, 32771 | |
| (407) 688-6765 | |
| Not Available |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 57 |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 102 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 901 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Sanford with elevated calcium levels.
| Patients with hypercalcemia | 108 |
| Hypercalcemia patient months | 951 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 110 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 130 |
| Patient months included in arterial venous fistula and catheter summaries | 760 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
The ACR works for the day when all medical errors are eliminated and welcomes input from all medical organizations. However, the recent United States Pharmacopeia (USP) study regarding medication error rates in medical imaging facilities is incomplete, inaccurate, may unnecessarily alarm patients, and may cause many patients who require imaging care to mistakenly avoid getting it
Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby's collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.
In a study detailed in the American Heart Association's journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.
One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 5 days ago